US FDA approves Sanofi's wearable injector form of blood cancer drug
- Posted on July 10, 2026
- By Bing News
- 0 Views
- 1 min read
US FDA approves Sanofi's wearable injector form of blood cancer drug
By Sneha S K and Bhanvi Satija July 10 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved a wearable form of Sanofi's blood cancer drug, Sarclisa, offering multiple myeloma patients a less burdensome alternative to intravenous infusions. It is the first cancer drug approved by the FDA that can be delivered through an on-body injector, attached to the skin. The